Actively Recruiting
Drug-coating Balloon Treatment in Coronary Artery Disease
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2024-11-15
3000
Participants Needed
1
Research Sites
565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.
CONDITIONS
Official Title
Drug-coating Balloon Treatment in Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients suitable for DCB treatment
You will not qualify if you...
- Pregnancy
- Contraindications to contrast media, antiplatelet therapy, or paclitaxel
- Expected life less than 12 months
- Cardiac shock
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanjing First Hospital
Nanjing, Jiangsu, China
Actively Recruiting
Research Team
J
Jun-Jie Zhang, MD
CONTACT
X
Xiao-Fei Gao, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here